COCRYSTAL PHARMA, INC. Business Acquisitions, Purchase Price Allocation, Subsequent Years, Remaining Adjustments
COCRYSTAL PHARMA, INC. (COCP) had Business Acquisitions, Purchase Price Allocation, Subsequent Years, Remaining Adjustments of $184.78 million as of 2016-12-31, per its 10-K filed 2017-03-31.
Discontinued › Notes › Financial Services
us-gaap:BusinessAcquisitionsPurchasePriceAllocationSubsequentYearsRemainingAdjustments · last filed 2017-03-31
- 2016-12-31: Business Acquisitions, Purchase Price Allocation, Subsequent Years, Remaining Adjustments $184.78M.
- 2014-12-31: Business Acquisitions, Purchase Price Allocation, Subsequent Years, Remaining Adjustments $184.78M; Business Acquisitions, Purchase Price Allocation, Subsequent Years, Remaining Adjustments as first filed $184.78M.
| Period end | Business Acquisitions, Purchase Price Allocation, Subsequent Years, Remaining Adjustments | Business Acquisitions, Purchase Price Allocation, Subsequent Years, Remaining Adjustments as first filed |
|---|---|---|
| 2016-12-31 | $184.78M 10-K · filed 2017-03-31 | |
| 2014-12-31 | $184.78M 10-K · filed 2016-03-15 | $184.78M 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |